Sonalis Consumer (543924)
Fast GrowerScore breakdown: P/E: 3/3 · ROCE: 2/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹72.47 |
| Market Cap | ₹14.8 Cr |
| P/E Ratio | 6.1 |
| ROCE | 43.32% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | 1,000% |
| Debt/Equity | — |
| Sales Growth | 91.24% |
| 52-Week Range | ₹42 — ₹92 |
| Sector | Food Products |
Strengths
- ROCE at 43.32% demonstrates strong capital efficiency
- Sales growth of 91.24% shows rapid expansion
- P/E of 6.10 and PEG of 0.01 indicate statistically cheap valuation
- Piotroski F-Score of 7/9 suggests decent financial health
- Latest quarter revenue of ₹88 Cr with net profit of ₹2 Cr shows operating scale
Concerns
- Market cap of only ₹15 Cr makes it a microcap with potential liquidity and volatility risk
- Critical data missing: promoter holding, book value, debt/equity, and ROE
- Net margin is thin at ~2.27% (₹2 Cr profit on ₹88 Cr sales)
- No dividend means returns solely depend on continued growth and re-rating
AI Analysis
Looking at Sonalis Consumer, my first instinct is caution. A ₹15 crore market cap with a P/E of 6.10 looks statistically cheap, but Graham taught me that a share of stock is a business, not just a number. The business shows real revenue momentum: sales grew 91.24%, and profit growth of 1000% sounds extraordinary, yet a 1000% profit increase often starts from a very small base. Latest quarter net profit of ₹2 crore on ₹88 crore sales is only a 2.27% net margin, reflecting a low-margin packaged-foods business. ROCE of 43.32% and Piotroski F-Score of 7/9 are encouraging; they indicate capital efficiency and reasonable balance-sheet health. But I cannot compute book value, ROE, or debt/equity because the data is missing. In a microcap, that lack of transparency is a red flag. The PEG ratio of 0.01 screams value, but with no dividend and no promoter-holding disclosure, the outsider investor is relying heavily on management integrity and future execution. Packaged foods in India is intensely competitive; there is no evidence of brand moat or pricing power. If the company is truly growing sales at 91% and generating strong ROCE, then at ₹72.47 with a P/E of 6.10, the market may be undervaluing it. But I would demand several more quarters of audited results, stable margins, and better corporate governance before committing. A wonderful business at a fair price is better than a statistically cheap one with unanswered questions; here, the onus is on proof, not hope.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer